Lamont Barlow
Urology · New York, NYNPI 1003134701
Payments from drug & device makers
What this record shows
Procept Biorobotics Corporation accounts for 65.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $2,056 and has fallen 90.4% since, to $198 in 2025.
Across 26 payments — averaging $118.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$2K
- Progenics Pharmaceuticals, Inc.$249
- Coloplast$198
- Photocure Inc$171
- Novo Nordisk$120
- Medtronic$94
- plus $231 from 6 others
Across 13 payments — averaging $53,112 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$690K
What the payments were for
- Travel & lodging$1,32743%
- Food & beverage$1,74357%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 11 | $2,007 |
| Progenics Pharmaceuticals, Inc. | 2 | $249 |
| Coloplast | 1 | $198 |
| Photocure Inc | 2 | $171 |
| Novo Nordisk | 1 | $120 |
| Medtronic | 1 | $94 |
| Regeneron Healthcare Solutions, Inc. | 1 | $89 |
| AbbVie | 3 | $66 |
| Neotract Inc. | 1 | $20 |
| Hollister Incorporated | 1 | $19 |
| ABC Home Medical Supply, Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$1,781
- PYLARIFY$249
- SPEEDICATH$198
- Cysview$152
How this compares
$3,069 in reported general payments places this provider in the 55th percentile of 952 urology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 207 | $97,299 |
| Tamsulosin Hcl | 452 | $3,949 |
| Mirabegron ErMirabegron | 11 | $3,205 |
| Oxybutynin Chloride ErOxybutynin Chloride | 278 | $2,499 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 17 | $1,795 |
| Estradiol | 26 | $1,369 |
| Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl | 13 | $1,235 |
| Dutasteride | 47 | $624 |
| Trospium Chloride | 20 | $615 |
| Finasteride | 94 | $374 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 16 | $214 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 16 | $174 |
| Solifenacin Succinate | 12 | $110 |
| Sildenafil Citrate | 14 | $86 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $68 |
Paid to pharmacies, not to this prescriber.
Other urology in New York
- Bilal ChughtaiNew York$658K
- Katie MurrayNew York$575K
- Neil BanderNew York$544K
- Robert ValenzuelaNew York$494K
- Kyrollis AttallaNew York$381K
- Benjamin BruckerNew York$364K
- Ketan BadaniNew York$285K
- Michael GrassoNew York$284K
- Mantu GuptaNew York$229K
- Robin SmithNew York$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.